Skip to content
HowShorted

CHEMBIO DIAGNOSTICS, INC. short interest in 2018

In 2018, CHEMBIO DIAGNOSTICS, INC.'s disclosed short interest ran from 0.81% of shares outstanding on 12 Jan 2018 to 0.49% on 31 Dec 2018, a change of -0.32 percentage points. The year's high was 0.87% on 15 Oct 2018 and its low 0.36% on 14 Dec 2018, averaging 0.56% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.90 days on 30 Apr 2018. Full history: CHEMBIO DIAGNOSTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for CHEMBIO DIAGNOSTICS, INC. in 2018

2018 in figures

Start of year
0.81% (12 Jan 2018)
End of year
0.49% (31 Dec 2018)
Change
-0.32 pp
High
0.87% (15 Oct 2018)
Low
0.36% (14 Dec 2018)
Average
0.56%
Highest days to cover
11.90 (30 Apr 2018)
SEC filings marked
7

Every report in 2018

CHEMBIO DIAGNOSTICS, INC. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20180.81%3.25
31 Jan 20180.74%7.71
15 Feb 20180.77%1.77results (8-K)
28 Feb 20180.77%2.70
15 Mar 20180.63%3.3510-K filed
29 Mar 20180.58%3.26
13 Apr 20180.52%7.34
30 Apr 20180.52%11.90
15 May 20180.45%1.8710-Q filed
31 May 20180.46%1.53
15 Jun 20180.46%1.26
29 Jun 20180.44%1.84
13 Jul 20180.49%3.99
31 Jul 20180.43%2.67
15 Aug 20180.43%2.2010-Q filed
31 Aug 20180.37%3.02
14 Sep 20180.44%2.97
28 Sep 20180.61%2.84
15 Oct 20180.87%6.10
31 Oct 20180.81%3.29results (8-K)
15 Nov 20180.54%1.0010-Q filed, results (8-K)
30 Nov 20180.37%1.00
14 Dec 20180.36%1.23
31 Dec 20180.49%1.00

See also: CHEMBIO DIAGNOSTICS, INC.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.